New FDA Approved Treatment for Hyperhidrosis – SLUCare Health Watch

More than 15 million Americans suffer from excessive sweating, called hyperhidrosis and have no idea they have options. Although excessive sweating is not considered to be a life-threatening condition, it can have a profound impact on daily life, making even simple tasks and interactions difficult.

Qbrexza is available to treat hyperhidrosis in patients ages 9 and up. SLUCare Dermatologist Dr. Dee Ana Glaser says, “We know that most of our patients who have hyperhidrosis, the disease process starts in childhood or early teens.” The first of its kind to hit the market, this treatment is a game-changer. Unlike other treatment options, Qbrexza is non-invasive, easy-to-use, and painless. “Patients will apply it at nighttime. They will sleep with it on. Then, take their shower. Put on their antiperspirant in the morning if they want to, and go about their day.”